SUNNYVALE, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc.
(Nasdaq: PCYC) today announced that it will hold a conference call to discuss
its fourth quarter and fiscal 2008 year-end financial results and
achievements, and 2009 guidance on Thursday, August 14, 2008, at 4:30 p.m. EDT
(1:30 p.m. PDT).
To participate in the conference call, please dial 800-497-0451 for
domestic callers and 706-758-3306 for international callers and reference
conference passcode 59146626. To access the live audio broadcast or the
subsequent archived recording, log on to http://www.pharmacyclics.com. The
archived version of the webcast will be available on the company's website for
one month.
About Pharmacyclics
Pharmacyclics is a pharmaceutical company developing innovative products
to treat cancer and other serious diseases. The company is leveraging its
small-molecule drug development expertise to build a pipeline in oncology and
immune diseases based on a wide range of targets, pathways and mechanisms.
More information about the company, its technology, and products can be found
at http://www.pharmacyclics.com. Pharmacyclics(R) and the "pentadentate"
logo(R) are registered trademarks of Pharmacyclics, Inc.
.gif)
